From the *Intensive Care Unit, Royal Children's Hospital, Melbourne, Australia; †National Public Health Institute, Helsinki, Finland; ‡KEMRI Wellcome Trust Collaborative Research Programme, Kilifi, Kenya; §Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; ¶Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Stellenbosch University, Cape Town, South Africa; and ∥Medical Research Council Laboratories, Fajara, The Gambia.
Accepted for publication November 3, 2009.
Supported by the Novo Nordisk Foundation, and the Danish National Research Foundation; the World Health Organization supported the participation of some of the delegates.
This paper is the product of a workshop that was held in London in April 2008. The workshop was organized by Peter Smith from the London School of Hygiene & Tropical Medicine.
Address for Correspondence: Frank Shann, MD, FRACP, Royal Children's Hospital, Parkville, Victoria 3052, Australia. E-mail: [email protected].
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.pidj.com).
